Amryt

Amryt is a global commercial-stage biopharmaceutical company developing treatments for rare and orphan diseases.

Rocky mountains snow
Biotech

Gene editor Metagenomi adds C-suite execs—Chutes & Ladders

Metagenomi names new CSO, CFO. Flagship taps ex-McKinsey leader to lead APEC office. Assembly adds another former Gilead leader as CMO.
Max Bayer , Gabrielle Masson Nov 10, 2023 9:30am
FDA Rejection no denied

Amryt's shares tumble as skin treatment spurned by FDA

Feb 28, 2022 11:49am